NCT05991349
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05991349
Title A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
St George private Hospital Kogarah New South Wales 2217 Australia Details
Wollongong Hospital Wollongong New South Wales 2500 Australia Details
Hubei Cancer Hospital Wuhan Hubei China Details
The First Hospital of Jilin University Changchun Jilin 130021 China Details
Shandong Cancer Hospital Jinan Shandong 250117 China Details
Tianjin Medical university cancer institute & Hospital Tianjin Tianjin Municipality 300000 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field